WHO ICTRP trial
Vemurafenib:Radiation Use During Vemurafenib Treatment
NCT02042040 · NIH Clinical Trials · Not recruiting
Key facts
| Trial ID | NCT02042040 |
|---|---|
| Public title | Vemurafenib:Radiation Use During Vemurafenib Treatment |
| Primary sponsor | University of Utah |
| Registry | NIH Clinical Trials |
| Recruitment status | Not recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | United States |
| Conditions | Melanoma |
| Interventions | Drug: Vemurafenib |
| Registration date | Oct 14, 2013 |
| Target size | 36 |
| Secondary IDs | HCI 64498 |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: